GSK aim for HIV cure by 2030

3 days 14 hours ago
Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.
Checked
1 hour 11 minutes ago
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Subscribe to Pharma times RSS Feed feed